SELLAS Life Sciences Group, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $17.4M | $21.4M | $14.3M |
| Jun 2022 | $13.2M | $32.2M | $27.0M |
| Sep 2022 | $13.4M | $26.0M | $21.3M |
| Dec 2022 | $16.1M | $20.9M | $17.1M |
| Mar 2023 | $15.9M | $29.1M | $23.9M |
| Jun 2023 | $13.7M | $18.6M | $13.8M |
| Sep 2023 | $11.9M | $8.1M | $4.0M |
| Dec 2023 | $14.2M | $6.2M | $2.5M |
| Mar 2024 | $14.8M | $24.4M | $18.4M |
| Jun 2024 | $12.2M | $15.1M | $9.1M |
| Sep 2024 | $10.6M | $26.5M | $21.0M |
| Dec 2024 | $10.0M | $19.4M | $13.9M |
| Mar 2025 | $7.2M | $35.0M | $28.4M |
| Jun 2025 | $6.2M | $32.3M | $25.3M |
| Sep 2025 | $5.9M | $51.6M | $44.3M |
| Dec 2025 | $7.5M | $78.3M | $71.8M |
| Mar 2026 | $6.8M | $114.2M | $107.1M |
| Jun 2026 | $7.7M | $145.4M | $138.3M |